Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2

Molecular and Cellular Biology

Volumn 28, Issue 24, 2008, Pages 7263-7273

  Vormer, Tinke L ^a   Foijer, Floris ^a,b   Wielders, Camiel L C ^a   Te Riele, Hein ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P53; PROTEIN TBX2; RAS PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ANCHORAGE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FIBROBLASTS; G2 PHASE; HUMANS; MICE; MICE, KNOCKOUT; MICE, NUDE; PROTEIN ISOFORMS; RAS PROTEINS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; T-BOX DOMAIN PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE; MUS MUSCULUS;

EID: 57349141873     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00313-08     Document Type: Article

References (50)

1. CIP1 via Cdc42/Rac1 signaling. Mol. Cell. Biol. 22:4587-4597.
2. Berthet, C., and P. Kaldis. 2007. Cell-specific responses to loss of cyclin-dependent kinases. Oncogene 26:4469-4477.
3. Boehm, J. S., M. T. Hession, S. E. Bulmer, and W. C. Hahn. 2005. Transformation of human and murine fibroblasts without viral oncoproteins. Mol. Cell. Biol. 25:6464-6474.
4. Burke, L., D. B. Flieder, D. G. Guinee, E. Brambilla, A. N. Freedman, W. P. Bennett, R. T. Jones, A. Borkowski, N. A. Caporaso, M. Fleming, V. Trastek, P. Pairolero, H. Tazelaar, D. Midthun, J. R. Jett, L. A. Liotta, W. D. Travis, and C. C. Harris. 2005. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin. Cancer Res. 11:232-241.
5. Kip1-deficient cells. Curr. Biol. 9:163-173.
6. Dannenberg, J. H., L. Schuijff, M. Dekker, M. van der Valk, and H. te Riele. 2004. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev. 18:2952-2962.
7. 1 control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14:3051-3064.
8. Dirac, A. M., and R. Bernards. 2003. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278:11731-11734.
9. Dobrzycka, K. M., K. Kang, S. Jiang, R. Meyer, P. H. Rao, A. V. Lee, and S. Oesterreich. 2006. Disruption of scaffold attachment factor B1 leads to TBX2 up-regulation, lack of p19ARF induction, lack of senescence, and cell immortalization. Cancer Res. 66:7859-7863.
10. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271:499-502.
11. Foijer, F., R. M. Wolthuis, V. Doodeman, R. H. Medema, and H. te Riele. 2005. Mitogen requirement for cell cycle progression in the absence of pocket protein activity. Cancer Cell 8:455-466.
12. Gad, A., M. Thullberg, J. H. Dannenberg, H. te Riele, and S. Stromblad. 2004. Retinoblastoma susceptibility gene product (pRb) and p107 functionally separate the requirements for serum and anchorage in the cell cycle G1-phase. J. Biol. Chem. 279:13640-13644.
13. Grana, X., J. Garriga, and X. Mayol. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365-3383.
14. Guadagno, T. M., and R. K. Assoian. 1991. G1/S control of anchorage-independent growth in the fibroblast cell cycle. J. Cell Biol. 115:1419-1425.
15. Guadagno, T. M., M. Ohtsubo, J. M. Roberts, and R. K. Assoian. 1993. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262:1572-1575.
16. Hahn, W. C., C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464-468.
17. Hahn, W. C., S. K. Dessain, M. W. Brooks, J. E. King, B. Elenbaas, D. M. Sabatini, J. A. DeCaprio, and R. A. Weinberg. 2002. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22:2111-2123.
18. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
19. Harvey, M., A. T. Sands, R. S. Weiss, M. E. Hegi, R. W. Wiseman, P. Pantazis, B. C. Giovanella, M. A. Tainsky, A. Bradley, and L. A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8:2457-2467.
20. Hurford, R. K., Jr., D. Cobrinik, M. H. Lee, and N. Dyson. 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447-1463.
21. ARF) and is amplified in a subset of human breast cancers. Nat. Genet. 26:291-299.
22. Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and C. J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649-659.
23. Kipling, D., and H. J. Cooke. 1990. Hypervariable ultra-long telomeres in mice. Nature 347:400-402.
24. Koh, E. Y., T. Chen, and G. Q. Daley. 2002. Novel retroviral vectors to facilitate expression screens in mammalian cells. Nucleic Acids Res. 30:e142.
25. Krimpenfort, P., K. C. Quon, W. J. Mooi, A. Loonstra, and A. Berns. 2001. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413:83-86.
26. Lukas, C., C. S. Sorensen, E. Kramer, E. Santoni-Rugiu, C. Lindeneg, J. M. Peters, J. Bartek, and J. Lukas. 1999. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 401:815-818.
27. Mahlamaki, E. H., M. Barlund, M. Tanner, L. Gorunova, M. Hoglund, R. Karhu, and A. Kallioniemi. 2002. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 35:353-358.
28. Marino, S., M. Vooijs, G. H. van Der Gulden, J. Jonkers, and A. Berns. 2000. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14:994-1004.
29. Meuwissen, R., S. C. Linn, R. I. Linnoila, J. Zevenhoven, W. J. Mooi, and A. Berns. 2003. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4:181-189.
30. Miwa, S., C. Uchida, K. Kitagawa, T. Hattori, T. Oda, H. Sugimura, H. Yasuda, H. Nakamura, K. Chida, and M. Kitagawa. 2006. Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner. Biochem. Biophys. Res. Commun. 340:54-61.
31. Nevins, J. R. 2001. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10:699-703.
32. Peeper, D. S., J. H. Dannenberg, S. Douma, H. te Riele, and R. Bernards. 2001. Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nat. Cell Biol. 3:198-203.
33. WAF1 cyclin-dependent kinase inhibitor. Cancer Res. 64:1669-1674.
34. Prowse, K. R., and C. W. Greider. 1995. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92:4818-4822.
35. Rangarajan, A., S. J. Hong, A. Gifford, and R. A. Weinberg. 2004. Species-and cell type-specific requirements for cellular transformation. Cancer Cell 6:171-183.
36. Rodier, G., C. Makris, P. Coulombe, A. Scime, K. Nakayama, K. I. Nakayama, and S. Meloche. 2005. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J. Cell Biol. 168:55-66.
37. Roovers, K., and R. K. Assoian. 2000. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22:818-826.
38. 1 control and immortalization. Genes Dev. 14:3037-3050.
39. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
40. INK4a and p53 deficiency cooperate in tumorigenesis. Cancer Res. 62:2761-2765.
41. ARF deficiency on cell growth and tumorigenesis. Oncogene 23:379-385.
42. Simin, K., H. Wu, L. Lu, D. Pinkel, D. Albertson, R. D. Cardiff, and D. T. Van Dijke. 2004. pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol. 2:E22.
43. Sinclair, C. S., C. Adem, A. Naderi, C. L. Soderberg, M. Johnson, K. Wu, L. Wadum, V. L. Couch, T. A. Sellers, D. Schaid, J. Slezak, Z. Fredericksen, J. N. Ingle, L. Hartmann, R. B. Jenkins, and F. J. Couch. 2002. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res. 62:3587-3591.
44. Vance, K. W., S. Carreira, G. Brosch, and C. R. Goding. 2005. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 65:2260-2268.
45. Vooijs, M., H. te Riele, M. van der Valk, and A. Berns. 2002. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene 21:4635-4645.
46. Voorhoeve, P. M., and R. Agami. 2003. The tumor-suppressive functions of the human INK4A locus. Cancer Cell 4:311-319.
47. Walker, J. L., A. K. Fournier, and R. K. Assoian. 2005. Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension. Cytokine Growth Factor Rev. 16:395-405.
48. Williams, J. P., T. Stewart, B. Li, R. Mulloy, D. Dimova, and M. Classon. 2006. The retinoblastoma protein is required for Ras-induced oncogenic transformation. Mol. Cell. Biol. 26:1170-1182.
49. Wu, R. C., and A. H. Schonthal. 1997. Activation of p53-p21waf1 pathway in response to disruption of cell-matrix interactions. J. Biol. Chem. 272:29091-29098.
50. Zhu, X., M. Ohtsubo, R. M. Bohmer, J. M. Roberts, and R. K. Assoian. 1996. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133:391-403.